Search Results

You are looking at 91 - 100 of 144 items for :

  • Refine by Access: All x
Clear All
Full access

Robust Response to Futibatinib in a Patient With Metastatic FGFR-Addicted Cholangiocarcinoma Previously Treated Using Pemigatinib

Anil K. Rengan and Crystal S. Denlinger

’s CA 19-9 level was 109 U/mL and her hepatic function was stable with a Child-Pugh score of A5. Treatment was complicated by anticipated anti- FGFR2 adverse effects, including grade 2 hyperphosphatemia (managed by diet and phosphate binders), grade 1

Full access

Uptake Rates of Novel Therapies and Survival Among Privately Insured Versus Publicly Insured Patients With Colorectal Cancer in Germany

Lina Jansen, Daniel Boakye, Elizabeth Alwers, Prudence R. Carr, Christoph Reissfelder, Martin Schneider, Uwe M. Martens, Jenny Chang-Claude, Michael Hoffmeister, and Hermann Brenner

derived from 5 lifestyle factors (smoking, alcohol consumption, diet, physical activity, and body mass index), as described previously. 13 The Charlson comorbidity index score 14 (adapted by Deyo et al 15 ) was derived from comorbidities that

Full access

Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors

Christina Teng, Venkatesha, Prunella L. Blinman, and Janette L. Vardy

surgery and/or chemotherapy for CRC. Procedures Prior to their initial visit to the SCSC patients completed comprehensive symptom patient-reported outcome (PRO) measures, including symptom questionnaire, distress screening, pain score, QoL, and diet

Full access

Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Peter F. Coccia, Alberto S. Pappo, Lynda Beaupin, Virginia F. Borges, Scott C. Borinstein, Rashmi Chugh, Shira Dinner, Jeanelle Folbrecht, A. Lindsay Frazier, Robert Goldsby, Alexandra Gubin, Robert Hayashi, Mary S. Huang, Michael P. Link, John A. Livingston, Yousif Matloub, Frederick Millard, Kevin C. Oeffinger, Diane Puccetti, Damon Reed, Steven Robinson, Abby R. Rosenberg, Tara Sanft, Holly L. Spraker-Perlman, Margaret von Mehren, Daniel S. Wechsler, Kimberly F. Whelan, Nicholas Yeager, Lisa A. Gurski, and Dorothy A. Shead

malignancy, effects of treatment on fertility, information on maintaining a healthy diet, and exercise/physical fitness during cancer treatment. 45 Cancer centers should adopt the appropriate evidence-based approach, which includes adult centers implementing

Full access

Preventive Health in Cancer Survivors: What Should We Be Recommending?

Linda S. Overholser and Carlin Callaway

health behavior counseling could vary based on type of HCP seen, cancer type and stage, and patient characteristics. For example, a 2009 survey of colorectal cancer survivors reported that discussions around health promotion and diet were more likely to

Full access

Biomarkers in Colorectal Cancer Screening

Minhhuyen T. Nguyen and David S. Weinberg

FIT cutoff value of 20 mcg/g. 8 Generally, patients prefer FIT to gFOBT because only one stool sample is required and no diet or medication alterations are needed. 7 FIT results can be quantified, which is useful when colonoscopy follow-up capability

Full access

Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe

Pelin Cinar, Timothy Kubal, Alison Freifeld, Asmita Mishra, Lawrence Shulman, James Bachman, Rafael Fonseca, Hope Uronis, Dori Klemanski, Kim Slusser, Matthew Lunning, and Catherine Liu

balanced diet, regular activity, and adequate sleep are also important. Consultation with a mental health provider or availability of virtual visits for meditation and crisis intervention teams may also provide some comfort during this challenging time

Full access

Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA

Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Yang Li, Qing-Nan Tang, Xue-Song Sun, Yu-Jing Liang, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, and Hai-Qiang Mai

male and female patients in this group. The sex difference in prognosis might be due to genetic variants, inappropriate diet, environmental tobacco smoke, and occupational exposures to formaldehyde and dusts in the intermediate-risk group. 35 – 37

Full access

Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors

Darren R. Feldman, Wendy L. Schaffer, and Richard M. Steingart

familiar with their increased likelihood of developing cardiovascular disease. Lifestyle changes should be highly encouraged. Patients should be given recommendations for adopting a heart-healthy diet and regular exercise as per the American Heart

Full access

Treatment and Survival Among Patients With Colorectal Cancer in Sub-Saharan Africa: A Multicentric Population-Based Follow-Up Study

Lucia Hämmerl, Nikolaus C.S. Mezger, Tobias P. Seraphin, Walburga Yvonne Joko-Fru, Mirko Griesel, Jana Feuchtner, Franck Gnahatin, Freddy Houéhanou Rodrigue Gnangnon, Nathan Okerosi, Phoebe Mary Amulen, Rolf Hansen, Margaret Ziona Borok, Carla Carrilho, Brahima Mallé, Clausina Ahoui Apendi, Nathan G. Buziba, Edom Seife, Biying Liu, Rafael Mikolajczyk, Donald M. Parkin, Eva J. Kantelhardt, and Ahmedin Jemal

association between the occurrence of CRC and a higher level of socioeconomic development due to the high prevalence of obesity, smoking, lack of physical activity, and unhealthy diet in economically developed countries. 2 – 5 As a result, CRC incidence rates